Managing Director
Elena Viboch is a managing director at General Catalyst, where she focuses on investing in life sciences. Her investments include ArriVent Biopharma, Cellanome, Dewpoint, Maze Therapeutics, Parabilis Medicines and Variant Bio, and she serves on the boards of ALLInBio, Faro Health, Paradigm and Pallando Therapeutics.
Prior to joining General Catalyst, Elena served as an investment director at SoftBank, where she helped build SoftBank Vision Fund’s healthcare portfolio, driving investments in companies such as Devoted Health and Vividion Therapeutics and serving on multiple boards. Earlier in her career, Elena worked in investing at Kearny Venture Partners and held operating roles at Carmot Therapeutics and NanoString. She’s passionate about working closely with rising entrepreneurs to help them bring their work from idea to execution to impact.
Elena holds a B.A. from Swarthmore College, an M.S. from Johns Hopkins University and an MBA from Harvard Business School where she graduated with highest honors as a Baker Scholar. Elena lives in San Francisco and enjoys hiking throughout the Bay Area.